Oncology & Cancer

Heparin derivative suppresses neuroblastoma tumor growth

Researchers at Duke Medicine have identified a new strategy for treating neuroblastoma using a modified version of heparin, a century-old injectable drug that thins the blood to prevent clots from forming.

Medical research

Brittle-bone babies helped by fetal stem cell grafts

Osteogeneis imperfecta (OI) is a congenital bone disease that causes stunted growth and repeated, painful fracturing. Ultrasound scans can reveal fractures already in the fetus, and now an international team of researchers ...

Medical research

Hybrid heart valve is strong, durable in early tests

A hybrid heart valve created from thin and highly elastic mesh embedded within layers of human cells was strong and durable in a study presented at the American Heart Association's Scientific Sessions 2013.

Oncology & Cancer

Molecular imaging predicts risk for abdominal aortic aneurysms

Several newly identified markers could provide valuable insight to predict the risk of rupture abdominal aortic aneurysms (AAA), according to new research published in the October issue of the Journal of Nuclear Medicine. ...

Medical research

Scientists identify superior heart repair product

A regenerative tissue product developed by a Perth health care group has the potential to help tissue heal better than existing products when used in cardiac repairs.

Medical research

Nontoxic scaffold developed: New skin for chronic wounds

The concept is amazing: a synthetic cell carrier is populated by skin cells and dissolves simultaneously. In just two years, the Lucerne-based company nolax and Empa have developed this project up to a first proof of concept ...

Oncology & Cancer

Self-perpetuating signals may drive tumor cells to spread

A team of international researchers from Duke-NUS Graduate Medical School Singapore and the Johns Hopkins University School of Medicine (USA) has identified a self-perpetuating signaling circuit inside connective tissue cells ...

page 12 from 16